Biodistribution of111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01
Helma M. Prinssen, Carla F. M. Molthoff, René H. M. Verheijen, Tim J. Broadhead, Peter Kenemans, Jan C. Roos, Quentin Davies, Arjan C. van Hof, Malcolm Frier, Wim den Hollander, Abraham J. Wilhelm, TeVolume:
47
Language:
english
Pages:
8
DOI:
10.1007/s002620050502
Date:
August, 1998
File:
PDF, 266 KB
english, 1998